-

Fresenius Kabi Celebrates 25th Anniversary of National Blood Donation Hall of Fame by Honoring 2023 Heroes

12 honorees nominated by blood centers across U.S. for commitment to blood donation programs

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi marked the 25th anniversary of its partnership with blood donation centers by naming the 12 newest inductees into the Fresenius Kabi National Blood Donation Hall of Fame. The latest honorees were nominated by blood centers across the United States for their exemplary commitment to donating blood and/or encouraging blood donation.

Fresenius Kabi marks 25th anniversary of its partnership with blood donation centers by naming the 12 newest inductees into the Fresenius Kabi National Blood Donation Hall of Fame. #BloodDonation #DonateBlood #BloodSupply #Heroes

Share

Joining the ranks of more than 300 prior honorees, this year’s inductees have donated blood hundreds of times, volunteered thousands of hours to blood donation centers, helped recruit new donors – and saved countless lives. Through their efforts, they have helped patients recover after surgery, survive traumatic injuries and battle cancer and other conditions.

"Blood donation is a selfless, life-saving act, and this year's inductees have made heroic contributions to bolster the blood supply, which is critically needed to care for patients, especially during the ongoing nationwide shortage,” said Dean Gregory, president, MedTech Global Commercial Operations at Fresenius Kabi. “Congratulations to those joining the National Blood Donation Hall of Fame, and heartfelt thanks for your honorable efforts in providing this vital resource to patients when it matters most. We hope their remarkable commitment serves as an inspiring call to action, encouraging others to roll up their sleeves and help meet the nation’s urgent need for blood donations."

The 2023 inductees are:

  • Sherman Hirsch, nominated by American Red Cross, North Platte, Neb.
  • Scott and Samantha Baker, nominated by OneBlood, Fort Myers, Fla.
  • Jim Walker, nominated by San Diego Blood Bank, San Diego, Calif.
  • Kirk Hunter, nominated by Carter BloodCare, Bedford, Texas
  • Larry Turner, nominated by Solvita Blood Center (formerly Community Blood Center), Dayton, Ohio
  • Yvonne Dauterive, nominated by LifeServe Blood Center, Des Moines, Iowa
  • Darlene Olson, nominated by Rhode Island Blood Center, Providence, R.I.
  • Robert L. Sihler, nominated by American Red Cross, Pasadena, Calif.
  • Pat Henry, nominated by LifeSouth Community Blood Centers, Atlanta, Ga.
  • Scott MacGregor, nominated by Vitalant, Folsom, Calif.
  • Nanette Allen, nominated by Vitalant, Rapid City, S.D.
  • Kelly Robinson, Versiti Blood Center of Illinois, Aurora, Ill.

National Blood Donation Hall of Fame inductees are featured in an annual calendar used by blood centers that highlights the stories about their contributions to this important cause. To read about the 2023 inductees, please visit BloodDonorHOF.com. To find a blood donation center, visit DonatingBlood.org.

About Fresenius Kabi

Fresenius Kabi (www.fresenius-kabi.com/us) is a global health care company that specializes in injectable medicines, biosimilars, and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used to help care for patients with critical and chronic conditions. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn.

Contacts

Joanie Clougherty, 614-717-5741
joan.clougherty@fresenius-kabi.com

Fresenius Kabi LogoFresenius Kabi Logo

Fresenius Kabi


Release Versions

Contacts

Joanie Clougherty, 614-717-5741
joan.clougherty@fresenius-kabi.com

Social Media Profiles
More News From Fresenius Kabi

Fresenius Kabi Recognized as a Top Employer in the United States for the Fourth Consecutive Year

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has been certified by the Top Employers Institute as a 2026 Top Employer in the United States and North America. This affirms the company’s ongoing commitment to creating a positive work environment. Globally, Fresenius Kabi was certified as a Top Employer for 2026 in 13 countries and two regions. Since 2023, Fre...

Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under which Fresenius Kabi has an exclusive license to develop, manufacture, and distribute products that incorporate TQ Therapeutics’ proprietary cell selection technology. The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing. Frese...

Fresenius Kabi Introduces New Presentation of Otulfi® (ustekinumab-aauz), a Biosimilar to Stelara®

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced a new presentation of Otulfi® (ustekinumab-aauz) in a 45 mg/0.5 mL single-dose vial for subcutaneous injection. Otulfi® is a prescription medicine and the brand name for Fresenius Kabi’s FDA-approved biosimilar of the reference product, Stelara® (ustekinumab). With this addition, Fresenius Kabi now offers...
Back to Newsroom